Chemotherapy is indicated for non-small cell<unk><unk>  stage (IB, II, and III) as adjuvant therapy. The main therapy for non-small cell<unk><unk>  is surgical resection. Chemotherapy and chemo-radiation may be required upon histological subtype of non-small cell<unk><unk> , location, size, and lymph node involvement. Commonly used chemotherapeutic agents include gemcitabine, paclitaxel, docetaxel, pemetrexed, etoposide or vinorelbine. Chemotherapeutic regimens are based on platinum agents such as cisplatin, carboplatin, oxaliplatin, and satraplatin. Alternative regimens include paclitaxel, gemcitabine, or etoposide. Chemotherapeutic regimens are adjusted based on individual characteristics and body surface. The regimen adjustment according to tumor evolution has demonstrated longer survival rates, optimal symptom control, and higher quality of life. Radiation therapy can be applied to any stage of non-small cell<unk><unk> . In general, radiation therapy is recommended as palliative care treatment among patients who develop an advanced stage of non-small cell<unk><unk>  or symptomatic patients with local involvement (pain, vocal cord paralysis, and hemoptysis). Curative radiation therapy may be indicated in patients who are not suitable for surgery with early-stage non-small cell<unk><unk> . The main goal of radiation therapy for non-small cell<unk><unk>  is maximum tumor control with minimal tissue toxicity. The two main types of radiation therapy for non-small cell<unk><unk>  are external beam radiation therapy (thoracic radiotherapy), and brachytherapy (internal radiation therapy).
Non small cell lung cancer medical therapy
Lung cancer medical therapy
Non small cell lung cancer chemotherapy
Squamous cell carcinoma of the lung medical therapy
Squamous cell carcinoma of the lung chemotherapy
Non small cell lung cancer radiation therapy
Lung mass medical therapy
Non small cell lung cancer management